Oncolytics Biotech Inc. (TSX:ONC)
Canada · Delayed Price · Currency is CAD 1.420
+0.030 (2.16%)
Inactive · Last trade price on Aug 22, 2025
Oncolytics Biotech Employees
Oncolytics Biotech had 28 employees as of December 31, 2024. The number of employees decreased by 1 or -3.45% compared to the previous year.
Employees
28
Change
-1
Growth
-3.45%
Revenue / Employee
n/a
Profits / Employee
-1.09M CAD
Market Cap
142.51M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28 | -1 | -3.45% |
| Dec 31, 2022 | 29 | 3 | 11.54% |
| Dec 31, 2021 | 26 | 1 | 4.00% |
| Dec 31, 2020 | 25 | - | - |
Oncolytics Biotech News
- 7 days ago - Oncolytics Biotech® Reschedules Special Meeting of Shareholders to Change Jurisdiction of Incorporation to Nevada - Business Wire
- 13 days ago - Oncolytics Biotech (ONCY) Loses 8.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Nasdaq
- 22 days ago - Oncolytics Biotech GAAP EPS of -C$0.14 - Seeking Alpha
- 26 days ago - Oncolytics Biotech® Provides Update on Special Meeting of Shareholders - Business Wire
- 27 days ago - Oncolytics Biotech (ONCY) Advances with FDA-Approved Study Design - GuruFocus
- 27 days ago - All You Need to Know About Oncolytics Biotech (ONCY) Rating Upgrade to Buy - Nasdaq
- 27 days ago - Oncolytics, FDA agree on phase 3 trial design for elareorep in pancreatic cancer - Seeking Alpha
- 27 days ago - Oncolytics Biotech® Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer - Business Wire